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ABSTRACT 
 
Cone snails are predatory marine gastropods that prey on worms, molluscs and fish. 
The venoms of these animals are true pharmacological treasures, and with the recent 
approval of the first cone snail venom-derived drug, the pressure on the resource is set to 
increase. While habitat loss and over-collecting for the shell trade are the major threat to 
cone snail diversity, every effort should be made to preserve this unique pharmacopoeia, 
including reducing to a minimum the number of specimens collected for scientific 
purposes. To this end, we show how recent improvements in sensitivity, miniaturisation 
of equipment, high throughput screens and novel technologies can help deliver valuable 
scientific and economic outcomes from small quantities of these limited samples.  
 
 
INTRODUCTION 
 
Natural products, such as those isolated from plants, animals and microbes, have been 
used to treat human diseases since the dawn of medicine (Harvey 2007). Nowadays, natural 
products or their derivatives still represent ~ 50 % of all approved drugs (Harvey 2008). This 
figure should not come as a surprise, since millions of years of evolution have often shaped 
these molecules into privileged structures that can be effective even via the oral route 
(Newman & Cragg 2009). While plant extracts remain the major source of novel bioactives, 
marine organisms have also been actively evaluated for a range of therapeutically useful 
properties, including anticancer and analgesic activities (Molinski et al. 2009).  
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Our knowledge of marine biodiversity is likely underestimated, especially regarding deep 
water forms of life because access to the resource is very restricted, rendering the sampling 
effort difficult and expensive (Richardson & Poloczanska 2008). Yet, the remarkable hit rates 
of marine compounds in screening for drug leads have maintained the interest of 
pharmaceutical companies (Newman & Cragg 2004). Therefore, the major hurdle to the 
development of an active marine compound into a drug remains the procurement or 
manufacturing of large quantities in a sustainable way. Many of the marine organisms of 
interest are difficult to breed or grow in vitro, implying that the only source of the compound 
is from wild harvest. While it is quite challenging to evaluate the full extent of marine 
bioprospecting, concerns over the overexploitation of endemic species or small local 
populations have emerged (Hunt & Vincent 2006). 
Recently, the approval of the first marine-derived drug for the treatment of intractable 
pain has further stimulated drug discovery programs from marine organisms (Miljanich 
2004). This molecule, a short peptide called ω-MVIIA or Ziconotide and marketed as Prialt, 
was originally discovered in the venom of the magician cone snail, Conus magus, as a potent 
blocker of N-type calcium channels (Olivera et al. 1985). Several other “conopeptides” 
targeting ion channels, transporters and receptors are in various stages of clinical trials for the 
treatment of pain, but also myocardial infarction, epilepsy and neurodegenerative diseases 
(Lewis 2009, Lewis & Garcia 2003). As a result, cone snail venoms are regarded as 
pharmacological treasures (Wang & Chi 2004).  
Cone snail venoms hold great promise for the discovery of new therapeutic leads, but 
unravelling their complex pharmacology and isolating minor individual active components 
from the thousands present in a single venom is challenging and typically requires significant 
amount of starting material. Historically, cone snails have been harvested from the wild, their 
venom gland dissected, the venom extracted from the venom duct, and the venom peptides 
tested in animals, isolated tissue preparations or a range of bioassays (Olivera et al. 1984). 
When more material is necessary to allow minor components to be characterised, further 
snails are collected, with tens to hundreds of cone snails sometimes necessary to obtain a 
single molecule of interest (Wang et al. 2009). This practise has been questioned as to 
whether it was sustainable and ethically acceptable (Chivian et al. 2003). Yet, a collective 
reply from researchers corrected that most world leading groups working with cone snail 
venoms are limited to 15-20 specimens per species per year (Duda et al. 2004). This number 
is dwarfed by the hundreds of thousands of snails harvested for the shell trade around the 
globe each year. Research efforts into the discovery of new drugs are certainly more valuable 
than ornamentation, with outcomes such as drugs that can directly benefit us. To allow access 
to the components from species that are small or more difficult to collect, most researchers 
are committed to further reduce the number of animals harvested from the wild using 
miniaturised approaches such as high throughput screening or next generation sequencing to 
accelerate discovery. In this chapter, we summarize the current knowledge on cone snail 
biology, and report on the recent improvements in various technologies that can produce high 
scientific and economic outcomes with minimal environmental impact.  
 
 
 
Cone Snail Biology, Bioprospecting and Conservation 3
CONE SNAIL BIOLOGY 
 
Taxonomy 
 
Conus is the type genus of the Conidae, which was validly established as a family by 
John Fleming in 1822 (Rockel et al. 1995). The Conidae together with the Turridae and 
Terebridae form the Superfamily Conoidea, also known as the Conacea or Toxoglossa 
(Rockel et al. 1995). As the largest genus of marine invertebrates, Conus arguably presents 
the most challenging taxonomy and nomenclature, with many new species described every 
year (Kohn 1980). Recently, a revised classification of the recent and fossil Conoidean 
gastropods has been published, based on radular morphology as well as other factors such as 
dietary habits and periostracum morphology (Tucker & Tenorio 2009). 
 
 
 
Habitat  
 
Generally, the genus Conus occurs throughout all tropical and subtropical oceans but is 
most diverse in the Indo-West Pacific region (Rockel et al. 1995). The few species found 
beyond the 40° N or S parallel are localized in South Africa, Southern Australia, Southern 
Japan and Mediterranean Sea. These marine snails are found mostly in coral reef areas, 
usually in shallow waters, under coral shelves, hiding in the sand, or under piles of rocks or 
rubble (Rockel et al. 1995). The density and diversity of cone snails decrease dramatically 
when the percentage of live corals is higher than 20 % (Kohn 1983). A maximum density of 
40 individuals per square meter can be attained but they are usually much less abundant 
(Kohn 2001). There are also some cone snails that live among mangroves, and a reasonable 
number live offshore or in the deep waters up to 400 metres. 
 
 
Reproductive Biology 
 
Reproduction in cone snails has not been widely studied, but it appears that most have 
separate sexes and are fertilized internally (Rockel et al. 1995). Eggs are laid once a year and 
attached to substrate in capsules, with each capsule containing a varying number of eggs. 
Typically, egg masses are made of up to 25 egg capsules, and each capsule may contain up to 
1,000 eggs. Therefore, each egg mass may contain about 25,000 eggs (Zehra & Perveen 
1991). Two types of offspring or hatchlings have been described, the veliger (free-swimming 
larvae) and veliconcha (juvenile snails) stages. These early development stages are critical, 
and a large number will not survive beyond the first few days after hatching. The pelagic 
stage occurs between 1 and 50 days (Perron 1983).  
In the life cycle of the genus Conus, larvae from the planktotrophic stage must feed on 
specific forms of plankton before settling and metamorphosing in the benthic environment. In 
a study of C. pennaceus, it was shown that over 99.93 % egg mortality occurs during this 
stage (Perron 1979). This critical larval stage has hampered most attempts to breed cone 
snails in captivity. The major hurdle is to find the correct food for each stage of development. 
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For instance, veliger larvae only feed on certain specific types of phytoplankton. After 
metamorphosis, the tiny cones shifts to a diet that may be very different compared to adults or 
larvae. Indeed, piscivorous cones were shown to produce a “vermivorous-like” radula in 
animals with a shell length < 10 mm, implying that young cone snails may feed on worms 
rather than fishes (Nybakken 1990). One study has reported the successful breeding of Conus 
(C. textile), and the conditions found to be essential include: flowing sea water, presence of a 
biological film for metamorphosis and an appropriate food source (Perron 1980). The life 
span of a cone snail is estimated to be 10-20 years in the wild as well as in captivity, based on 
shell growth rate and marks. They can reach a maximum size of > 20 cm, but most species 
are < 8 cm and weight < 100 g (Rockel et al. 1995). 
 
 
Behaviour 
 
The adult cone snail hides under rocks or buries itself in sand during the day. Cone snails 
are usually solitary, but some species can be found in great numbers in particular areas, 
mainly due to their specialised habitats (i.e. a microhabitat) (Kohn 2001). At night, cone 
snails become active, leave their retreat and search for prey. Cone snails are highly 
specialised predators with some species feeding exclusively on worms (70%), molluscs (15%) 
or fishes (15%) (Rockel et al. 1995) (figure 1). Prey is detected using chemosensor organs 
such as the osphradium. The snail crawls towards it, extends its proboscis, and upon contact 
with any soft part of the body fires a barbed harpoon-like modified radula into the prey. The 
venom is injected through this hollowed tooth and envenomation proceeds rapidly, usually 
followed by paralysis. A few species will engulf the prey before stinging, including the 
deadly C. geographus. 
In the presence of a threat such as a potential predator, a different behaviour can be 
described. Firstly, the cone snail retreats into its shell, which represents an inviolable fortress 
for many predators. If the threat remains or intensifies, and while still hidden under its shell, 
the cone snail will extend its proboscis and wave it around, trying to sting the predator. 
Human accidents involving Conus stings are a consequence of this defensive behaviour 
(Olivera & Cruz 2001).  
Among the 700 species of cone snails, only Conus geographus has been confirmed as 
responsible for several human deaths (Kohn 1958). It is estimated that more than 55% of 
stings from C. geographus may be fatal to humans, but such encounters are fortunately rare 
(Fegan & Andresen 1997). Over 30 human fatalities from C. geographus stings have been 
recorded in the medical literature (Alan J. Kohn, personal communication). Symptoms from a 
cone snail sting vary depending on the species, with extreme pain or a spreading numbness 
followed by paralysis often reported (McIntosh & Jones 2001). In general, the venoms of 
fish-hunting species are more lethal to vertebrates and most of the vermivorous and 
molluscivorous species are considered harmless to humans (Kohn et al. 1960). Cone snails 
are not aggressive by nature, and most accidents occur when a snail is picked up by divers 
and pressed against a wetsuit, or when collectors attempt to clean the shell of a live animal.  
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Figure 1. Live cone snails in their environment. Cone snails are marine predators that prey on worms, 
mollusks and fish. Upper panel shows two piscivorous species, Conus geographus (left) and Conus 
striatus (right). Middle section illustrates two molluscivorous species, namely Conus marmoreus (left) 
and Conus textile (right). Bottom panel shows two vermivorous species, Conus coccineus (left) and 
Conus vitulinus (right). Photos from Thierry Vulliet. 
 
Venom Apparatus 
 
Cone snails have evolved a specialised venom apparatus to subdue their prey. It is 
comprised of a venom gland, salivary glands (and accessory salivary glands), a radular sac, a 
pharynx, a proboscis and a radula (Marsh 1977) (figure 2). A cone snail's radula acts as a 
delivery system, and is hollowed and barbed to resemble a miniature harpoon up to 10 mm 
long (Kohn et al. 1972). These harpoons are produced and stored in a specialised organ, the 
radular sac, which is divided into two arms and connects to the pharynx (Marsh 1977). The 
short arm of the radular sac contains a limited number of mature, fully formed radula, while 
the long arm is the site of production, where radula in different stages of synthesis can be 
found. The total number of radula present in a radular sac is species-dependant, and seems to 
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vary according to the feeding habits (e.g. molluscivorous snails, which can inject venom 
multiple times into their prey, produce larger number of harpoons, see table 1). While the 
cone snail is hunting, a single radula is loaded from the short arm of the radular sac to the tip 
of the long and extendable proboscis (Salisbury et al. 2010). When the snail senses a prey it 
will extend its proboscis and fire the harpoon via a powerful muscular contraction, injecting a 
potent venom (Schulz et al. 2004). The average attack lasts only milliseconds and the prey is 
usually paralysed within a second.  
 
 
Figure 2. The venom apparatus of cone snails. This panel illustrates the dissected venom apparatus of 
Conus striatus.  
Table 1. Number of radulas stored in the radular sac per species. 
 
Species Diet Short arm Long arm Total 
C. miles V 1 18 19 
C. striatus P 6 34 40 
C. geographus P 23 27 50 
C. marmoreus M 13 61 74 
C. textile M 29 46 75 
V, vermivorous; P, piscivorous; M, molluscivorous. 
 
Conotoxins and various enzymes are produced in a long, convoluted duct connected to 
the pharynx (distal end) next to the radular sac, and is linked to a musclar bulb at the other 
extremity (proximal end). Some toxins are only expressed in particular regions of the venom 
duct, as demonstrated using molecular biology and mass spectrometry methods (Garrett et al. 
2005, Marshall et al. 2002). It is interesting to note here that comparison of the venom 
contents extracted from the duct and the milked venom (ejected from the radula) from the 
same animal revealed significant differences (Biass et al. 2009, Jakubowski et al. 2005). 
Indeed, while a number of compounds were common to both venoms, up to 50 % of the 
masses detected in the injected venom were unique. Therefore, other organs such as the 
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salivary glands may participate in the elaboration of the injected venom, as demonstrated for 
Conus pulicarius (Biggs et al. 2008). 
 
 
Venom Pharmacology 
 
The venom of cone snails has evolved to rapidly subdue their prey. As a result, the 
biological effects seen following the injection of venom into the prey are often reminiscent of 
muscle paralysis and complete nervous system shut down. If the venom is fractionated and 
each fraction injected into the brain of a mouse, then a multitude of pharmacological actions 
are observed (Olivera et al. 1990). Indeed, the venom of cone snails is made up of over a 
thousand small disulfide rich peptides, as well as numerous proteins, amino acids and small 
molecules (Davis et al. 2009). Each of these conotoxins potentially targets an ion channels or 
other key membrane receptors with exquisite potency and selectivity; the challenge is to find 
its target (Dutertre & Lewis 2010). An impressive number of pharmacological targets for 
conotoxins have already been identified, but more are likely to be revealed in the future, ever 
expanding the use and applications of these peptides (see table 2). 
 
Table 2. Pharmacology of Conus peptides. 
 
Class Mode of action example 
ω-conotoxin Cav2.2 inhibitor MVIIA 
μ-conotoxin Nav inhibitor SIIIA 
μO-conotoxin Nav1.8 inhibitor MrVIB 
δ-conotoxin Nav enhancer EVIA 
κ-conotoxin Kv inhibitor PVIIA 
χ-conopeptide NET inhibitor  Xen2174 
α-conotoxin nAChR inhibitor Vc1.1 
σ-conotoxin 5HT3 R antagonist GVIIIA 
ρ-conopeptide α1-adrenoceptor inhibitor TIA 
Conantokin NMDAR antagonist conantokin-G 
Conopressin Vasopressin agonist conopressin-G 
Contulakin neurotensinR agonist contulakin-G 
 
 
BIO-PROSPECTING 
 
Bioprospecting is broadly defined as the exploration of biodiversity for commercial 
and/or scientific purposes to generate valuable genetic and biochemical resources (Arico & 
Salpin 2005). Clearly, the primary goal of such activity is often to find novel molecules to 
cure human diseases. Plants, microbes and marine invertebrates are currently the main focus 
of academic and industrial discovery programs (Harvey 2008). Indeed, more than half of our 
modern medicines are or derived from natural chemical compounds provided by nature 
(Harvey 2007). Among the most famous natural compounds is the antibiotic penicillin which 
was derived from a type of mould. More recently, the cancer drug taxol isolated from the bark 
of the yew tree has found important uses in the management of cancer. 
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Venoms are now subject to more intense investigation. While a number of traditional 
medications derived from the venom of snakes, spiders and frogs have shown promise over 
the years (Harvey 2002), the relative infancy of venom peptide bioprospecting is mainly due 
to the difficulty in obtaining the material, and to the nature of the active components of 
venoms, which comprise mainly small proteins and peptides. Indeed, proteinaceous 
molecules have long been regarded as poor drug candidates, due to their poor bioavailability 
and short half-life in biological fluids such as blood and serum. Peptides typically have 
greater selectivity and affinity compared to small molecules, providing better efficacy and 
safety, and potentially fewer side effects. In addition, novel chemical strategies have greatly 
improved the stability and oral-bioavailability of peptides (Clark et al. 2005, Clark et al. 
2010, Muttenthaler et al. 2010). As a result, we are now observing a surge of interest in 
peptide-based drugs from pharmaceutical companies. 
Conservative estimates suggest each venomous animal may contain between 50 and 200 
active components in their venom (Escoubas et al. 2006), although recent reports on cone 
snail venoms indicated numbers at least an order of magnitude higher (Biass et al. 2009, 
Davis et al. 2009). There are more than 40,000 species of spiders and 10,000 species of 
venomous marine snails, indicating that natural libraries of millions of bioactive compounds 
can be generously produced by these animals. It is estimated that for the cone snails alone, 
less than 2% of the biodiversity has been uncovered, and less than 1% has been 
pharmacologically characterised (Kaas et al. 2008). With so many potential compounds and 
organisms to choose from, how should scientists proceed with their bioprospecting efforts? It 
mostly depends on the target of interest, the equipment and assays available to each 
laboratory. Naturally, the largest, the most abundant, and medically important species were 
initially studied. Early work aimed at understanding the lethality of Conus geographus, the 
only species of cone snail responsible for human deaths (Olivera et al. 1999). Other large 
species such as C. textile, C. striatus, and C. marmoreus have also been intensively 
investigated. Yet, small, rare or inoffensive species may be just as interesting and promising 
as the common or larger species. Unfortunatley, many of the rarer species are also of great 
interest to collectors, and scientists rarely get a chance to study them. Collectors are only 
interested in the shell, and discard the animal inside, while scientists often break the shell to 
access the tissues of interest. A better communication and cooperation between scientists and 
collectors may actually be rewarding to both parties.  
From a recent study on all conotoxin sequences deposited in the online database 
Conoserver, it appears that toxins extracted from species of the Atlantic regions or South 
African region and/or belonging to clades IX, X and XV are underrepresented, whereas others 
have not yet been studied at all (e.g., clade IV) (Kaas et al. 2008). Therefore, research efforts 
targeted at these species are likely to uncover novel molecules of interest. Understandably, 
deep water species, as well as endemic species to remote places have largely eluded 
bioprospecting efforts. Novel techniques of collecting, in close association with local 
populations, are likely to provide interesting specimens from this untapped biodiversity 
(Seronay et al. 2009). 
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CONSERVATION 
 
Scientific investigations have so far mostly focused on common species of cones snails, 
and therefore the impact of collecting for scientific purposes has remained limited. By far the 
most serious threat to cone snail diversity is the destruction of their habitat, which in most 
cases consists of fragile reef ecosystems (Rockel et al. 1995). Coral reefs around the world 
are threatened by pollution, destructive fishing practices, coastal developments and mass 
tourism, not to mention acidification and warming of oceans due to climate change. The 
collection of large number of shells for the ornamentation trade may also contribute to the 
decline of some species. However, it should also be mentioned here that none of the 700 
species of cone snails is listed on CITES (Convention on International Trade in Endangered 
Species). Nonetheless, concerns about overharvesting some cone snail species for research 
purposes have emerged, with estimates of “hundreds of thousands” sacrificed annually 
(Chivian et al. 2003). While there is no statistical study on the extent of cone snail harvesting, 
these numbers were largely overestimated (Duda et al. 2004). Nowadays, the number of 
specimens collected for research in most laboratories ranges from tens to even one single 
animal per species annually. Indeed, thanks to continuous improvements in sensitivity and 
miniaturisation of analytical methods and high throughput screening assays, small samples 
from a unique specimen can nowadays yield large amount of data (see figure 3). A brief 
overview of some of the strategies that can reduce the number wild-collected animals for 
research is given below. 
 
 
Figure 3. Current strategies to maximize scientific outcomes from a unique specimen. Here we illustrate 
how a single specimen of cone snail can generate a large amount of data, including genomic, 
transcriptomic and proteomic data. 
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High Throughput Screening (HTS) Assays  
 
A range of HTS platforms are already available (such as fluorescence resonance energy 
transfer or homogeneous time resolved fluorescence), permitting the screening of thousands 
of samples per day. The miniaturization of HTS assays is an important objective for the 
pharmaceutical industry as well as for fundamental science (Houston & Banks 1997). 
Miniaturisation is one way to access and evaluate a greater diversity of compounds from very 
limited samples such as natural extracts. One critical step is the reduction of the volume in 
which the assay is performed so that the concentration of the active compounds reaches levels 
high enough to produce a detectable response. Currently, typical assay volumes in 96 well 
plates are in the range of 50–500 μl with a medium throughput potential of about 20,000 
assays per day. Assay volumes can be reduced to 10 μl using 384 well plates, increasing the 
throughput to 50,000 assays per day. The development of even higher throughput in 1536 
well format should allow assay volumes to be reduced to less than 5 μl, potentially opening 
further novel discovery opportunities.  
 
 
Mass Spectrometry 
 
Mass spectrometry has become the method of choice to study the complexity of venoms 
(Escoubas 2006). In particular, soft ionisation technologies such as matrix-assisted laser 
desorption-ionization (MALDI) and electrospray (ESI) are heavily utilised to unravel the 
composition of these proteinaceous mixtures (Davis et al. 2009, Escoubas et al. 2008). While 
venoms can be studied as a whole sample (mass fingerprinting, profiling), they are usually 
pre-fractionated for better resolution, diminution of the ion suppression effect and higher 
coverage. A liquid chromatography step can be carried out off-line (MALDI) or online (ESI), 
each method providing high quality yet complementary data sets (Biass et al. 2009). Recent 
improvements in sensitivity (dynamic range) and accuracy of mass spectrometers are 
allowing high throughput analysis from minute samples (Nilsson et al. 2010). For instance, 
using a combined Orbitrap-ETD with a targeted chemical derivatization strategy, the full 
sequences of 31 peptide toxins could be obtained from just 7% of the crude venom of a single 
Conus textile (Ueberheide et al. 2009).  
 
 
Transcriptomics 
 
The Human Genome Project, with the unprecedented throughput requirement for DNA 
sequencing, has fuelled the development of novel technologies that can benefit many different 
research projects, including those dealing with non-model organisms such as cone snails 
(Metzker 2010). The so-called “next-generation sequencing” technologies, as opposed to the 
traditional Sanger sequencing, have delivered on the promise of sequencing DNA at 
unprecedented speed, thereby enabling impressive scientific achievements and novel 
biological applications (Morozova et al. 2009). While several different platforms are 
available, the 454-pyrosequencing technology (Roche) provides the longest reads (300–350 
bp on average), ensuring a more accurate assembly of contigs in the absence of a reference 
genome (Droege & Hill 2008, Margulies et al. 2005). Next generation sequencing 
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technologies are not limited to genome projects, and are particularly relevant to venom-based 
discovery projects. Transcriptome analysis of venom gland transcripts have the potential to 
reveal all toxin sequences in one single experiment (Hu et al. 2011). Unfortunately, the high 
prevalence of post-translational modifications in cone snails venom peptides preclude a direct 
discovery process from transcriptomic data alone, and proteomic data integration is required. 
 
 
Sustainable Venom Production 
 
Dissection and tissue extraction have been the methods of choice for cone snail venom 
collection for decades. The procedure consists of collecting tens or hundreds of cone snails, 
snap freezing them and extracting the venom gland. This simple procedure is still highly 
successful, leading to the discovery of a number of interesting compounds from cone snail 
venoms, including the marketed pain killer (Ziconotide) (Olivera 2006). However, venom can 
be obtained from live cone snails in a similar way that snakes and spiders are "milked" for 
their venom to manufacture the life-saving anti-venom and to provide the scientific 
community with "natural libraries of compounds" (Hopkins et al. 1995). While this is a 
tedious procedure and only amenable to certain species, it provides many advantages. Milked 
venoms are free of cellular debris and contain few traces of unprocessed toxins and 
degradation products when compared to dissected venoms. In addition, milked venoms have a 
much higher solubility compared to dissected venoms. The milked venom from piscivorous 
cone snails is highly soluble as opposed to the thick paste obtained after venom duct 
dissection. This unique property of milked venom appears well-suited to biological screening 
assays and should facilitate the discovery of novel pharmacological tools and drug leads 
(Bingham et al. 2009). Some conotoxins are abundantly expressed in the milked venom, and 
in some cases, direct HPLC purification may provide sufficient material for structural studies. 
Furthermore, venom composition can be compared between individuals using mass 
spectrometry, and can be followed over time to reveal dramatic and unexpected intraspecimen 
variations (Dutertre et al. 2010). Finally, unique and original molecules are found only in the 
milked venoms. Indeed, other organs may participate in the elaboration of the injected venom, 
such as the salivary glands or the radular sac (Biggs et al. 2008, Marshall et al. 2002). The 
specific molecules produced in these organs are obviously absent in the venom obtained from 
the dissection of the venom duct only. Further work is clearly needed to discover how to milk 
more cone snail species and to better understand the specific role of each organ in venom 
production. Given milking is a sustainable collection method that requires only small number 
of individual per species, and it avoids sacrificing the animals, these efforts may be well 
rewarded. 
 
 
CONCLUSIONS AND PERSPECTIVES 
 
In the near future, marine bioprospecting efforts will likely focus not only on natural 
extracts from ocean plants, animals, and microbes, but also on the genetic information stored 
in the genomes and transcriptomes of these organisms. Thanks to the Human Genome 
Project, the expertise and technology assembled now benefits sequencing of non-human 
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genomes. The genome and venom gland transcriptome of one species of Conus has been 
published already (Hu et al. 2011) and more can be expected in the future. Coupled to high 
throughput mass spectrometry and miniaturised biossays, these integrated approaches will 
likely increase the rate of discovery from this valuable resource. 
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